22859398|t|Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
22859398|a|BACKGROUND: To evaluate the association of variation in genes involved in immune response, including IL10, production and detoxification of reactive oxygen species, and repair of oxidative DNA damage with risk of recurrence after surgery for localized prostate cancer. METHODS: We conducted a nested case-control study of men who had a radical prostatectomy in 1993 to 2001. A total of 484 recurrence cases and 484 controls were matched on age, race, and pathologic stage and grade. Germline DNA was extracted from paraffin-embedded unaffected lymph nodes. We genotyped candidate single-nucleotide polymorphisms (SNP) in IL10, CRP, GPX1, GSR, GSTP1, hOGG1, IL1B, IL1RN, IL6, IL8, MPO, NOS2, NOS3, SOD1, SOD2, SOD3, TLR4, and TNF and tagging SNPs in IL10, CRP, GSR, IL1RN, IL6, NOS2, and NOS3. We used conditional logistic regression to estimate OR and 95% confidence intervals (CI). RESULTS: The minor allele (A) in IL10 rs1800872, known to produce less interleukin-10 (IL-10), was associated with a higher risk of recurrence (OR = 1.76, 95% CI: 1.00-3.10), and the minor allele (G) in rs1800896, known to produce more IL-10, was associated with a lower risk of recurrence (OR = 0.66, 95% CI: 0.48-0.91). We also observed associations for candidate SNPs in CRP, GSTP1, and IL1B. A common IL10 haplotype and 2 common NOS2 haplotypes were associated with recurrence. CONCLUSION: Variation in IL10, CRP, GSTP1, IL1B, and NOS2 was associated with prostate cancer recurrence independent of pathologic prognostic factors. IMPACT: This study supports that genetic variation in immune response and oxidation influence prostate cancer recurrence risk and suggests genetic variation in these pathways may inform prognosis.
22859398	13	17	IL10	GeneOrGeneProduct	3586
22859398	87	102	prostate cancer	DiseaseOrPhenotypicFeature	D011471
22859398	216	220	IL10	GeneOrGeneProduct	3586
22859398	255	278	reactive oxygen species	ChemicalEntity	D017382
22859398	367	382	prostate cancer	DiseaseOrPhenotypicFeature	D011471
22859398	437	440	men	OrganismTaxon	9606
22859398	630	638	paraffin	ChemicalEntity	D010232
22859398	736	740	IL10	GeneOrGeneProduct	3586
22859398	742	745	CRP	GeneOrGeneProduct	1401
22859398	747	751	GPX1	GeneOrGeneProduct	2876
22859398	753	756	GSR	GeneOrGeneProduct	2936
22859398	758	763	GSTP1	GeneOrGeneProduct	2950
22859398	765	770	hOGG1	GeneOrGeneProduct	4968
22859398	772	776	IL1B	GeneOrGeneProduct	3553
22859398	778	783	IL1RN	GeneOrGeneProduct	3557
22859398	785	788	IL6	GeneOrGeneProduct	3569
22859398	790	793	IL8	GeneOrGeneProduct	3576
22859398	795	798	MPO	GeneOrGeneProduct	4353
22859398	800	804	NOS2	GeneOrGeneProduct	4843
22859398	806	810	NOS3	GeneOrGeneProduct	4846
22859398	812	816	SOD1	GeneOrGeneProduct	6647
22859398	818	822	SOD2	GeneOrGeneProduct	6648
22859398	824	828	SOD3	GeneOrGeneProduct	6649
22859398	830	834	TLR4	GeneOrGeneProduct	7099
22859398	840	843	TNF	GeneOrGeneProduct	7124
22859398	864	868	IL10	GeneOrGeneProduct	3586
22859398	870	873	CRP	GeneOrGeneProduct	1401
22859398	875	878	GSR	GeneOrGeneProduct	2936
22859398	880	885	IL1RN	GeneOrGeneProduct	3557
22859398	887	890	IL6	GeneOrGeneProduct	3569
22859398	892	896	NOS2	GeneOrGeneProduct	4843
22859398	902	906	NOS3	GeneOrGeneProduct	4846
22859398	1031	1035	IL10	GeneOrGeneProduct	3586
22859398	1036	1045	rs1800872	SequenceVariant	rs1800872
22859398	1069	1083	interleukin-10	GeneOrGeneProduct	3586
22859398	1085	1090	IL-10	GeneOrGeneProduct	3586
22859398	1201	1210	rs1800896	SequenceVariant	rs1800896
22859398	1234	1239	IL-10	GeneOrGeneProduct	3586
22859398	1372	1375	CRP	GeneOrGeneProduct	1401
22859398	1377	1382	GSTP1	GeneOrGeneProduct	2950
22859398	1388	1392	IL1B	GeneOrGeneProduct	3553
22859398	1403	1407	IL10	GeneOrGeneProduct	3586
22859398	1431	1435	NOS2	GeneOrGeneProduct	4843
22859398	1505	1509	IL10	GeneOrGeneProduct	3586
22859398	1511	1514	CRP	GeneOrGeneProduct	1401
22859398	1516	1521	GSTP1	GeneOrGeneProduct	2950
22859398	1523	1527	IL1B	GeneOrGeneProduct	3553
22859398	1533	1537	NOS2	GeneOrGeneProduct	4843
22859398	1558	1573	prostate cancer	DiseaseOrPhenotypicFeature	D011471
22859398	1725	1740	prostate cancer	DiseaseOrPhenotypicFeature	D011471
22859398	Negative_Correlation	rs1800896	D011471	Novel
22859398	Positive_Correlation	rs1800872	D011471	Novel
22859398	Association	3553	D011471	Novel
22859398	Association	2950	D011471	Novel
22859398	Association	1401	D011471	Novel
22859398	Association	3586	D011471	Novel
22859398	Association	4843	D011471	Novel